Parnax Lab is currently trading at Rs. 59.95, up by 7.90 points or 15.18% from its previous closing of Rs. 52.05 on the BSE.The scrip opened at Rs. 54.90 and has touched a high and low of Rs. 60.80 and Rs. 54.55 respectively. So far 46,000 shares were traded on the counter.The BSE group `X` stock of face value Rs. 10 has touched a 52 week high of Rs. 78.00 on 24-Apr-2017 and a 52 week low of Rs. 40.20 on 28-Mar-2018.Last one week high and low of the scrip stood at Rs. 60.80 and Rs. 48.05 respectively. The current market cap of the company is Rs. 50.99 crore.The promoters holding in the company stood at 62.59%, while Non-Institutions held 37.41% stake in the company.Parnax Lab’s subsidiary -- Naxpar Pharma has received an export order amounting to 4.44 million euro.Parnax Lab is also known as Naxpar and its key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc.

Parnax Lab has informed that the Board of Directors of the Company at its meeting held on August 12, 2016.The above information is a part of company’s filings submitted to BSE.

Parnax Lab has informed that the Meeting of the Board of Directors of the Company will be held on May 30, 2016 to consider and approve, the Company’s Standalone and Consolidated audited Financial Results for the fourth quarter and year ended on March 31, 2016. In terms of the Code of Conduct for Prevention of Insider Trading in Securities of Parnax Lab, the Trading Window shall remain closed from May 11, 2016 to June 01, 2016 i.e. from the eleventh day of the month following the quarter till 48 hours from the time the results are communicated to the Stock Exchanges on the date of the Meeting.The above information is a part of company’s filings submitted to BSE.

Parnax Lab has informed about standalone financial results, consolidated financial results, and standalone limited review for the period ended December 31, 2015The above information is a part of company’s filings submitted to BSE.

Parnax Lab has informed that on account of declaring the unaudited financial results for the 1st Quarter ended on June 30th, 2015 and as per Company’s Code of Conduct for prevention of Insider Trading, the Trading Window for dealing in securities of the Company is closed for all Directors, Designated Employees and other persons covered under the Code from July 22, 2015 till the expiry of 48 hours after the announcement of the Financial Results of the Company.The above information is a part of company’s filings submitted to BSE.

Parnax Lab has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.The above information is a part of company’s filings submitted to BSE.

Parnax Lab has informed that a meeting of the Board of Directors of the Company will be held on March 31, 2015,to appoint Independent women director / women director in the Company.The above information is a part of company’s filings submitted to BSE.

Parnax Lab has informed about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013.The above information is a part of company’s filings submitted to BSE.

Parnax Lab has informed about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2013.The above information is a part of company’s filings submitted to BSE.

Parnax Lab has informed about the Financial Results for the period ended March 31, 2013.The above information is a part of company’s filings submitted to BSE.

Krishna Deep Trade & Investments has informed that the register of members & share transfer books of the company will remain closed from September 21, 2012 to September 28, 2012 for the purpose of annual general meeting (AGM) of the company to be held on September 28, 2012.The above information is a part of company's filings submitted to BSE.

Krishna Deep Trade & Investments has informed that a meeting of the board of directors of the company will be held on January 16, 2012, to consider the allotment of shares pursuant to scheme of merger to the transferor companies and to approve the new name of the company.The above information is part of the company’s filing submitted to the BSE.